FWM
SRPT icon

Focused Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Focused Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40
Closed -$3.86K – 866
2023
Q4 		$3.86K Hold
40
– – ﹤0.01% 691
2023
Q3 		$4.85K Hold
40
– – ﹤0.01% 648
2023
Q2 		$4.58K Hold
40
– – ﹤0.01% 690
2023
Q1 		$5.51K Sell
40
-110
-73% -$14.3K ﹤0.01% 648
2022
Q4 		$19.4K Hold
150
– – ﹤0.01% 430
2022
Q3 		$17K Sell
150
-162
-52% -$16.3K ﹤0.01% 426
2022
Q2 		$23K Sell
312
-1
-0.3% -$74 ﹤0.01% 383
2022
Q1 		$24K Sell
313
-2,656
-89% -$203K ﹤0.01% 415
2021
Q4 		$267K Sell
2,969
-393
-12% -$33.6K 0.04% 147
2021
Q3 		$311K Sell
3,362
-253
-7% -$19.5K 0.05% 123
2021
Q2 		$281K Sell
3,615
-407
-10% -$30.9K 0.05% 135
2021
Q1 		$300K Buy
4,022
+2,438
+154% +$225K 0.05% 130
2020
Q4 		$270K Sell
1,584
-294
-16% -$43.6K 0.05% 132
2020
Q3 		$264K Sell
1,878
-5,465
-74% -$831K 0.06% 123
2020
Q2 		$1.18M Sell
7,343
-73
-1% -$9.93K 0.27% 47
2020
Q1 		$725K Sell
7,416
-53
-0.7% -$6.06K 0.21% 55
2019
Q4 		$964K Sell
7,469
-647
-8% -$65.3K 0.23% 55
2019
Q3 		$611K Sell
8,116
-964
-11% -$114K 0.17% 72
2019
Q2 		$1.38M Sell
9,080
-926
-9% -$113K 0.37% 43
2019
Q1 		$1.19M Buy
10,006
+240
+2% +$30.9K 0.36% 45
2018
Q4 		$1.07M Buy
9,766
+585
+6% +$73.2K 0.36% 47
2018
Q3 		$1.48M Buy
+9,181
New +$1.26M 0.5% 39

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Focused Wealth Management's SRPT Position: Q1 2024 in Review

Focused Wealth Management sold out of Sarepta Therapeutics (SRPT) in Q1 2024, closing a stake of 40 shares — an estimated $3.86K sold.

Focused Wealth Management first reported a position in SRPT in Q3 2018 and held it in 22 quarters. The position peaked at $1.48M in Q3 2018. 414 funds tracked by Wall St. Rank hold SRPT as of Q1 2024.

  • Focused Wealth Management reported no remaining Sarepta Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 40 Sarepta Therapeutics shares in Q1 2024, an estimated $3.86K.
  • Focused Wealth Management first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 22 quarters.
  • Focused Wealth Management's Sarepta Therapeutics position peaked at $1.48M in Q3 2018.
  • 414 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.